GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen Marseille SA (STU:IPK) » Definitions » Research & Development

Qiagen Marseille (STU:IPK) Research & Development : €3.51 Mil (TTM As of Dec. 2014)


View and export this data going back to . Start your Free Trial

What is Qiagen Marseille Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Qiagen Marseille's Research & Development for the six months ended in Dec. 2014 was €2.02 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2014 was €3.51 Mil.


Qiagen Marseille Research & Development Historical Data

The historical data trend for Qiagen Marseille's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen Marseille Research & Development Chart

Qiagen Marseille Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Research & Development
Get a 7-Day Free Trial 3.88 3.10 3.62 3.64 3.51

Qiagen Marseille Semi-Annual Data
Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 1.89 1.76 1.49 2.02

Qiagen Marseille Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2014 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qiagen Marseille  (STU:IPK) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Qiagen Marseille Research & Development Related Terms

Thank you for viewing the detailed overview of Qiagen Marseille's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen Marseille Business Description

Traded in Other Exchanges
N/A
Address
Qiagen Marseille SA develops molecular diagnostic tests designed to map diseases in order to guide patients and oncologists decisions along their complex therapeutic path.

Qiagen Marseille Headlines

No Headlines